Malaria as a Protection Factor Against Severe COVID-19 (Known as SARS-COV-2) in the Democratic Republic of Congo (Palu-COVID)
Clinical trial NCT05012280 · TERMINATED
Trial details
- NCT number
- NCT05012280
- Sponsor
- Institute of Tropical Medicine, Belgium
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2021-09-04
- Primary completion
- 2022-08-17
- Enrollment
- 238
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.